TUMOR IMMUNOLOGY

[1] BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1

[2] GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO

[3] 2-Q

[4] EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B-CELL LYMPHOPROLIFERATION [J]. TRANSPLANTATION, 1985, 39 (05) : 461 - 472

[5] HERBERMAN RB, 1983, ADV HOST DEFENSE MEC, V2, P241

[6] Herberman RB, 1982, NATURAL KILLER CELLS

[7] HERBERMAN RB, 1977, MECHANISMS TUMOR IMM, P175

[8] KLEIN G, 1977, TRANSPLANT P, V9, P1095

[9] PREHN RT, 1957, J NATL CANCER I, V18, P769

[10] Rosenberg S A, 1986, Important Adv Oncol, P55

[1] BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1

[2] GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO

[3] 2-Q

[4] EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B-CELL LYMPHOPROLIFERATION [J]. TRANSPLANTATION, 1985, 39 (05) : 461 - 472

[5] HERBERMAN RB, 1983, ADV HOST DEFENSE MEC, V2, P241

[6] Herberman RB, 1982, NATURAL KILLER CELLS

[7] HERBERMAN RB, 1977, MECHANISMS TUMOR IMM, P175

[8] KLEIN G, 1977, TRANSPLANT P, V9, P1095

[9] PREHN RT, 1957, J NATL CANCER I, V18, P769

[10] Rosenberg S A, 1986, Important Adv Oncol, P55